结直肠癌遗传关联研究的系统荟萃分析与全球证据评估
该研究通过系统文献回顾纳入869篇文献,提取303个基因中1063个多态性数据,对158个基因的308个SNP进行荟萃分析,并应用Venice标准和BFDP评估关联可信度。初始识别16个位点18个独立变异为“阳性”,49个位点59个变异为“较可信阳性”;72.2%的“阳性”SNP在三个大型GWAS中重复验证,未重复者降级后“阳性”变异减至11个位点14个。
要点
- CRCgene2数据库提供经统一方法评估可信度的结直肠癌风险遗传变异清单。
- 初始18个“阳性”变异中72.2%在三个大型GWAS中成功重复验证。
- 未重复验证的“阳性”变异降级为“较可信阳性”,最终阳性变异为11个位点14个。
核心结论
- CRCgene2数据库通过统一方法评估可信度,提供了与结直肠癌风险相关的遗传变异更新列表。
研究设计与样本
- 系统文献回顾纳入869篇出版物,提取303个不同基因中1063个多态性的数据。
- 对158个不同基因中308个SNP进行荟萃分析,每个SNP至少有3项独立研究可用。
- 纳入苏格兰、加拿大和西班牙的GWAS数据,对132个SNP进行荟萃分析。
- 应用Venice标准和贝叶斯假发现概率(BFDP)评估和分类关联可信度。
- 将“阳性”和“较可信阳性”遗传关联在三个欧洲人群大型GWAS联盟中进一步验证。
主要发现
- 初始识别16个位点18个独立变异为“阳性”多态性,因其与结直肠癌风险的关联高度可信。
- 识别49个位点59个变异为“较可信阳性”SNP。
- 72.2%的“阳性”SNP在三个大型GWAS中成功重复验证。
- 未重复验证的“阳性”SNP降级为“较可信阳性”,使“阳性”变异减少至11个位点14个。
- 对剩余231个先前报道的变异,荟萃分析未发现支持其与结直肠癌风险关联的证据。
关键数值与推荐
- 应用Venice标准和贝叶斯假发现概率(BFDP)对遗传关联的可信度进行评估和分类。
- “阳性”多态性定义为与结直肠癌风险关联高度可信的独立变异。
- “较可信阳性”SNP定义为关联可信度次之的变异。
- 重复验证在三个欧洲人群大型GWAS联盟中进行。
临床怎么用
- CRCgene2数据库可用于查询经统一方法评估可信度的结直肠癌风险相关遗传变异。
- 临床解读结直肠癌遗传风险变异时应参考其可信度分类(阳性或较可信阳性)。
- 未在大型GWAS中重复验证的阳性变异应降级解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide an understanding of the role of common genetic variations in colorectal cancer (CRC) risk, we report an updated field synopsis and comprehensive assessment of evidence to catalogue all genetic markers for CRC (CRCgene2). DESIGN: We included 869 publications after parallel literature review and extracted data for 1063 polymorphisms in 303 different genes. Meta-analyses were performed for 308 single nucleotide polymorphisms (SNPs) in 158 different genes with at least three independent studies available for analysis. Scottish, Canadian and Spanish data from genome-wide association studies (GWASs) were incorporated for the meta-analyses of 132 SNPs. To assess and classify the credibility of the associations, we applied the Venice criteria and Bayesian False-Discovery Probability (BFDP). Genetic associations classified as 'positive' and 'less-credible positive' were further validated in three large GWAS consortia conducted in populations of European origin. RESULTS: We initially identified 18 independent variants at 16 loci that were classified as 'positive' polymorphisms for their highly credible associations with CRC risk and 59 variants at 49 loci that were classified as 'less-credible positive' SNPs; 72.2% of the 'positive' SNPs were successfully replicated in three large GWASs and the ones that were not replicated were downgraded to 'less-credible' positive (reducing the 'positive' variants to 14 at 11 loci). For the remaining 231 variants, which were previously reported, our meta-analyses found no evidence to support their associations with CRC risk. CONCLUSION: The CRCgene2 database provides an updated list of genetic variants related to CRC risk by using harmonised methods to assess their credibility.
引用
- Montazeri Z, Li X, Nyiraneza C, et al. Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. Gut. 2019. PMID: 31818908. doi:10.1136/gutjnl-2019-319313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。